Wall Street trims Robinhood price targets after Q3 earnings, but some analysts see a buying opportunity
As seen on the 24/7 Wall St. homepage on October 28, 2026.
Rosenblatt is holding a $135 Buy on Robinhood and calling the post-earnings slide an entry point.
Wall Street cuts its price targets on Robinhood $HOOD following its Q3 earnings, despite several analysts seeing a buying opportunity: Rosenblatt: $135 (Buy) – Maintains target; sees earnings-related weakness as a buying opportunity amid strong growth initiatives. Truist: $134 https://t.co/W1UkKlifmW
- Replies2
- Reposts4
- Likes17
Continue ReadingShow less
After Robinhood's Q3 earnings report, several Wall Street firms lowered their price targets on the stock, reflecting a reassessment of near-term expectations. The cuts were broad enough to draw attention, yet not uniform enough to signal a bearish consensus.
Rosenblatt is holding its Buy rating with a $135 price target, declining to lower it at all. The firm calls post-earnings weakness an entry point, pointing to what it describes as strong growth initiatives.
Sponsored
Twelve Tabs, One Thesis
Your Research Resets Every Morning
The quote page in one tab. Filings in another. A chart you rebuilt from scratch, a transcript you never went back and found, a screener whose settings you will redo next week. Nothing you built yesterday is still there.
AlphaSpace replaces all of it with one screen you arrange yourself. Earnings calendar, estimate versus actual, the call transcript, live news, your own charts, every panel wired to whatever ticker you click. Close the browser and it is all still sitting there tomorrow.
See What a Built View Looks Like →
(Sponsor)
Truist trimmed its target to $134, according to the TipRanks summary. The truncated tweet indicates additional analyst views beyond the two names shown, so Wall Street's full reaction is wider than what is visible.
The split between firms cutting targets and firms calling the dip a buying opportunity is the tension investors should keep an eye on. Whether the earnings-related slide holds or reverses will likely depend on how the market weighs short-term target reductions against the bullish longer-term cases being made by firms like Rosenblatt.
Mentioned: HOOD